Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 28;37(4):281-302.
doi: 10.7555/JBR.37.20230021.

A historical literature review of coronary microvascular obstruction and intra-myocardial hemorrhage as functional/structural phenomena

Leonid N Maslov  1 , Natalia V Naryzhnaya  1 , Sergey V Popov  1 , Alexandr V Mukhomedzyanov  1 , Ivan A Derkachev  1 , Boris K Kurbatov  1 , Andrey V Krylatov  1 , Feng Fu  2 , Jianming Pei  2 , Vyacheslav V Ryabov  1 , Evgenii V Vyshlov  1 , Svetlana V Gusakova  3 , Alla A Boshchenko  1 , Akpay Sarybaev  4
Affiliations

A historical literature review of coronary microvascular obstruction and intra-myocardial hemorrhage as functional/structural phenomena

Leonid N Maslov et al. J Biomed Res. .

Abstract

The analysis of experimental data demonstrates that platelets and neutrophils are involved in the no-reflow phenomenon, also known as microvascular obstruction (MVO). However, studies performed in the isolated perfused hearts subjected to ischemia/reperfusion (I/R) do not suggest the involvement of microembolization and microthrombi in this phenomenon. The intracoronary administration of alteplase has been found to have no effect on the occurrence of MVO in patients with acute myocardial infarction. Consequently, the major events preceding the appearance of MVO in coronary arteries are independent of microthrombi, platelets, and neutrophils. Endothelial cells appear to be the target where ischemia can disrupt the endothelium-dependent vasodilation of coronary arteries. However, reperfusion triggers more pronounced damage, possibly mediated by pyroptosis. MVO and intra-myocardial hemorrhage contribute to the adverse post-infarction myocardial remodeling. Therefore, pharmacological agents used to treat MVO should prevent endothelial injury and induce relaxation of smooth muscles. Ischemic conditioning protocols have been shown to prevent MVO, with L-type Ca 2+ channel blockers appearing the most effective in treating MVO.

Keywords: heart; intra-myocardial hemorrhage; ischemia; microvascular obstruction; reperfusion.

PubMed Disclaimer

Conflict of interest statement

The authors reported no conflict of interests.

Figures

Figure 1
Figure 1
The pathogenesis of microvascular obstruction.
Figure 2
Figure 2
Triggers of microvascular obstruction and contributing factors.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Krug A, Rochemont DM de, Korb G Blood supply of the myocardium after temporary coronary occlusion. Circ Res. 1966;19(1):57–62. doi: 10.1161/01.RES.19.1.57. - DOI - PubMed
    1. Majno G, Ames A, Chiang J, et al No reflow after cerebral ischemia. Lancet. 1967;290(7515):569–570. doi: 10.1016/S0140-6736(67)90552-1. - DOI
    1. Summers WK, Jamison RL The no reflow phenomenon in renal ischemia. https://pubmed.ncbi.nlm.nih.gov/5129762/ Lab Invest. 1971;25(6):635–643. - PubMed
    1. Kloner RA, Ganote CE, Jennings RB The ‘no-reflow’ phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54(6):1496–1508. doi: 10.1172/JCI107898. - DOI - PMC - PubMed
    1. Schofer J, Montz R, Mathey DG Scintigraphic evidence of the ‘no reflow’ phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol. 1985;5(3):593–598. doi: 10.1016/S0735-1097(85)80381-8. - DOI - PubMed